Encapsulated Cell Therapy for Diabetes

About ALTUCELL

Altucell is a preclinical-stage biotech company pioneering a microencapsulation platform for cell and regenerative therapies targeting major chronic diseases. Its initial focus appears to be on diabetes, with potential applications in autoimmune and neurodegenerative conditions, aiming to provide long-term therapeutic solutions without chronic immunosuppression. The company is privately held and likely pre-revenue, advancing its research through partnerships and its scientific advisory network. Its value proposition centers on a potentially broadly applicable encapsulation technology designed to protect transplanted cells from immune rejection.

Therapeutic Areas